George and Christine Sosnovsky Award in Cancer Therapy

The George and Christine Sosnovsky Award in Cancer Therapy recognises outstanding accomplishments in the prevention, control and cure of cancers using chemotherapy, including gene and immunotherapy.

Rules and Criteria

• Run biennially
• Open to everyone without restrictions
• Candidates are permitted to nominate themselves
• One page CV for the candidate which should include their date of birth, website URL, summary of education and career, a list of 5 relevant publications, total numbers of publications and patents
• A one page supporting statement addressing the selection criteria
• Nominations open 1 September 2009 
• Nominations close 31 January 2010 
• Award winner will be chosen by the Chemistry Biology Interface Forum Awards Committee
• Award winner receives £2000, a medal and a certificate  

About the Award

The George & Christine Sosnovsky Award in Cancer Therapy recognises their contributions to the chemical sciences community. 

Dr Christine Sosnovsky's research experience has been extensive in the fields of surface chemistry and physics. She spent 8 years in Australia at the University of Melbourne and subsequently moved to America to pursue her research further and later deliver lectures also. Her research included: investigating properties of metals and semiconductors, polycrystalline and single crystal organic solids and thin films. Her background comprises of studies of the effects of crystal orientation, surface structure and lattice defects on the catalytic properties of solids.

Professor George Sosnovsky's research interests have covered a wide range of topics to include research and development of fungicides, herbicides and insecticides, amidine derivatives as antiradiation agents, free radical chemistry, oxidative phosphorylation reactions and the synthesis of spin-labeled phosphorous compounds of biological interest, including anticancer agents. More recently, his interests have focused on medicinal chemistry, specifically the structure-activity relationships of anticancer drugs involving design and biological evaluations of new anticancer drugs. Additionally there were pursuits in the synthesis of contrast-enhancing agents for diagnostic purposes.